17.72
Precedente Chiudi:
$16.56
Aprire:
$16.42
Volume 24 ore:
24.78M
Relative Volume:
1.44
Capitalizzazione di mercato:
$3.95B
Reddito:
$8.22B
Utile/perdita netta:
$28.95M
Rapporto P/E:
-295.33
EPS:
-0.06
Flusso di cassa netto:
$901.06M
1 W Prestazione:
-1.56%
1M Prestazione:
-21.14%
6M Prestazione:
+4.11%
1 anno Prestazione:
+29.91%
Oscar Health Inc Stock (OSCR) Company Profile
Nome
Oscar Health Inc
Settore
Industria
Telefono
(646) 403-3677
Indirizzo
75 VARICK STREET, NEW YORK
Confronta OSCR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
OSCR
Oscar Health Inc
|
17.72 | 4.28B | 8.22B | 28.95M | 901.06M | -0.06 |
|
UNH
Unitedhealth Group Inc
|
324.21 | 291.28B | 435.16B | 18.37B | 17.37B | 19.16 |
|
CVS
Cvs Health Corp
|
78.99 | 99.85B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
ELV
Elevance Health Inc
|
317.78 | 69.88B | 194.82B | 5.53B | 3.77B | 24.45 |
|
CI
Cigna Group
|
264.58 | 68.49B | 268.22B | 6.55B | 7.44B | 22.67 |
|
HUM
Humana Inc
|
252.04 | 30.20B | 123.11B | 1.58B | 2.44B | 13.03 |
Oscar Health Inc Stock (OSCR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-14 | Iniziato | Goldman | Neutral |
| 2025-07-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-07-15 | Downgrade | UBS | Neutral → Sell |
| 2025-07-14 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-07-11 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2025-07-02 | Iniziato | Barclays | Underweight |
| 2025-06-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2025-03-13 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-12-10 | Iniziato | Jefferies | Underperform |
| 2024-11-06 | Downgrade | BofA Securities | Neutral → Underperform |
| 2024-10-07 | Iniziato | UBS | Neutral |
| 2024-06-26 | Iniziato | Piper Sandler | Overweight |
| 2024-05-30 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-05-30 | Iniziato | Robert W. Baird | Outperform |
| 2024-03-22 | Iniziato | Raymond James | Outperform |
| 2023-11-02 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-06-06 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-11-16 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-11-14 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-06-15 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-05-26 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-02-14 | Downgrade | Goldman | Neutral → Sell |
| 2022-01-06 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2021-12-14 | Iniziato | Goldman | Sell |
| 2021-09-10 | Iniziato | Cowen | Market Perform |
| 2021-03-30 | Iniziato | Wells Fargo | Overweight |
| 2021-03-29 | Iniziato | BofA Securities | Buy |
| 2021-03-29 | Iniziato | Cowen | Market Perform |
| 2021-03-29 | Iniziato | Credit Suisse | Outperform |
| 2021-03-29 | Iniziato | Goldman | Buy |
| 2021-03-29 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Oscar Health Inc Borsa (OSCR) Ultime notizie
Oscar Health (NYSE:OSCR) Price Target Raised to $12.00 - MarketBeat
Does Oscar Health Inc. qualify in momentum factor screeningWeekly Stock Recap & Consistent Growth Stock Picks - newser.com
Oscar Health Inc. stock prediction for this weekJuly 2025 Retail & AI Based Buy/Sell Signal Reports - newser.com
Oscar Health, Inc. (NYSE:OSCR) Given Consensus Rating of "Reduce" by Analysts - MarketBeat
How Oscar Health Inc. Class A (OSCR) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Oscar Health’s Earnings Call: Growth Amid Challenges - TipRanks
OSCR: UBS Maintains "Sell" Rating, Raises Price Target to $12 | - GuruFocus
New Leverage Shares ETFs Let Traders Go 2X On Lululemon — And Other Companies - Benzinga
Oscar Health (NYSE:OSCR) Shares Gap Up After Better-Than-Expected Earnings - MarketBeat
Oscar Health Q3 2025 Earnings Report: Revenue Miss, 2026 StrategyNews and Statistics - IndexBox
Oscar Health outlines 28% rate hikes for 2026 as pricing strategy adapts to higher morbidity - MSN
OSCR Q3 Deep Dive: Margin Pressures and Market Morbidity Shape Outlook - TradingView
Positive Sentiment Still Eludes Oscar Health, Inc. (NYSE:OSCR) Following 26% Share Price Slump - simplywall.st
Oscar Health (OSCR) Reports Strong Q3 Revenue and Membership Gro - GuruFocus
Oscar Health Inc (OSCR) Q3 2025 Earnings Call Highlights: Revenue Growth Amid Operational Challenges - Investing.com Canada
Has Oscar Health Inc. formed a bullish divergenceMarket Activity Report & Fast Exit Strategy with Risk Control - newser.com
Is Oscar Health’s Story Shifting as Analysts Weigh New Risks and Opportunities? - Yahoo Finance
Oscar Health Reports Q3 2025 Financial Results - TipRanks
Oscar Health, Inc. (OSCR) Reports Q3 Loss, Lags Revenue Estimates - sharewise.com
Compared to Estimates, Oscar Health (OSCR) Q3 Earnings: A Look at Key Metrics - sharewise.com
Is It Time to Look at Oscar Health? - timothysykes.com
Oscar Health Shares Jump After Narrowing Loss and Reaffirming Outlook - MSN
Oscar’s Growing Pains: Membership Climbs, Losses DeepenOscar Health (NYSE:OSCR) - Benzinga
Will Oscar Health Inc. Class stock beat revenue estimatesWeekly Trend Report & AI Forecasted Stock Moves - newser.com
Oscar Health, Inc. Reaffirms Earnings Guidance for the Full Year 2025 - MarketScreener
Oscar Health’s Revenue Rises But Losses Worry Wall Street - Finimize
Press Release: Oscar Health Announces Financial Results for Third Quarter 2025 and Reaffirms 2025 Guidance - 富途牛牛
Earnings call transcript: Oscar Health Q3 2025 sees EPS beat, stock rises - Investing.com
Oscar Health (OSCR) Aims for Profitability with Strategic Actions - GuruFocus
Oscar Health beats on adjusted EPS by a penny, CEO says it will “return to profitability” in 2026 - Sherwood News
Oscar Health (OSCR) Q3 Earnings Miss Estimates Despite Revenue G - GuruFocus
Oscar Health (OSCR) Reports Third Quarter Revenue Below Expectat - GuruFocus
Oscar Health Q3 Loss Widens, Revenue Rises; Reaffirms 2025 Revenue Guidance - MarketScreener
(OSCR) Oscar Health Expects Full Year 2025 Total Revenue Range $12B$12.2B, vs. FactSet Est of $12.01B - MarketScreener
Earnings Flash (OSCR) Oscar Health Posts Q3 Net Loss $0.53 a Share, vs. FactSet Est of $0.48 Loss - MarketScreener
Oscar Health (OSCR) Projects Significant Operational Losses for Fiscal Year 2025 - GuruFocus
Earnings Flash (OSCR) Oscar Health, Inc. Reports Q3 Revenue $2.99B, vs. FactSet Est of $3.07B - MarketScreener
Is Oscar Health Inc. trending in predictive chart modelsMarket Sentiment Summary & Weekly Momentum Stock Picks - newser.com
Oscar Health Enters $250M Exchange Agreement with Oasis - TipRanks
Oscar Health shares surge 8% after beating third quarter earnings expectations - Investing.com Philippines
Oscar Health Q3 revenue misses estimates, reaffirms guidance - MarketScreener
Oscar Health (NYSE:OSCR) Misses Q3 Revenue Estimates, But Stock Soars 7.8% - Yahoo Finance
Oscar Health Announces Financial Results for Third Quarter 2025 and Reaffirms 2025 Guidance - Bluefield Daily Telegraph
Can technical indicators confirm Oscar Health Inc.’s reversalWeekly Gains Report & Daily Oversold Bounce Ideas - newser.com
Oscar Health Launches New Affordable Health Insurance Choices for Charlotte Individuals and Families - MarketScreener
Sentiment analysis tools applied to Oscar Health Inc.July 2025 Trends & Target Return Focused Stock Picks - newser.com
Will Oscar Health Inc. stock benefit from AI adoptionJuly 2025 Chart Watch & Long Hold Capital Preservation Tips - fcp.pa.gov.br
Oscar Health Inc. stock daily chart insightsWeekly Stock Analysis & Daily Stock Trend Reports - newser.com
What MACD signals say about Oscar Health Inc.July 2025 Reactions & Verified Stock Trade Ideas - newser.com
Is Oscar Health Inc. stock resilient to inflationJuly 2025 Weekly Recap & Reliable Intraday Trade Plans - newser.com
Is Oscar Health Inc. stock a top pick in earnings seasonGap Down & Weekly Setup with High ROI Potential - newser.com
Oscar Health Inc Azioni (OSCR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):